Archives of Pharmacal Research

  • 제29권10호
  • /
  • Pages.911-920
  • /
  • 2006
  • /
  • 0253-6269(pISSN)
  • /
  • 1976-3786(eISSN)
대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

In vivo Pharmacokinetics, Activation of MAPK Signaling and Induction of Phase II/III Drug Metabolizing Enzymes/Transporters by Cancer Chemopreventive Compound BHA in the Mice

  • Hu, Rong (Graduate Program in Pharmaceutical Science, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey) ;
  • Shen, Guoxiang (Graduate Program in Pharmaceutical Science, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey) ;
  • Yerramilli, Usha Rao (Graduate Program in Pharmaceutical Science, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey) ;
  • Lin, Wen (Graduate Program in Pharmaceutical Science, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey) ;
  • Xu, Changjiang (Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey) ;
  • Nair, Sujit (Graduate Program in Pharmaceutical Science, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey) ;
  • Kong, Ah-Ng Tony (Graduate Program in Pharmaceutical Science, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey,Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey)
  • 발행 : 2006.10.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Phenolic antioxidant butylated hydroxyanisole (BHA) is a commonly used food preservative with broad biological activities, including protection against chemical-induced carcinogenesis, acute toxicity of chemicals, modulation of macromolecule synthesis and immune response, induction of phase II detoxifying enzymes, as well as its undesirable potential tumor-promoting activities. Understanding the molecular basis underlying these diverse biological actions of BHA is thus of great importance. Here we studied the pharmacokinetics, activation of signaling kinases and induction of phase II/III drug metabolizing enzymes/transporter gene expression by BHA in the mice. The peak plasma concentration of BHA achieved in our current study after oral administration of 200 mg/kg BHA was around $10\;{\mu}M$. This in vivo concentration might offer some insights for the many in vitro cell culture studies on signal transduction and induction of phase II genes using similar concentrations. The oral bioavailability (F) of BHA was about 43% in the mice. In the mouse liver, BHA induced the expression of phase II genes including NQO-1, HO-1, ${\gamma}-GCS$, GST-pi and UGT 1A6, as well as some of the phase III transporter genes, such as MRP1 and Slco1b2. In addition, BHA activated distinct mitogen-activated protein kinases (MAPKs), c-Jun N-terminal kinase (JNK), extracellular signal-regulated protein kinase (ERK), as well as p38, suggesting that the MAPK pathways may play an important role in early signaling events leading to the regulation of gene expression including phase II drug metabolizing and some phase III drug transporter genes. This is the first study to demonstrate the in vivo pharmacokinetics of BHA, the in vivo activation of MAPK signaling proteins, as well as the in vivo induction of Phase II/III drug metabolizing enzymes/transporters in the mouse livers.

키워드

참고문헌

  1. Babich, H. and Borenfreund, E., Cytotoxic effects of food additives and pharmaceuticals on cells in culture as determined with the neutral red assay. J. Pharm. Sci., 79, 592-594 (1990) https://doi.org/10.1002/jps.2600790709
  2. Benson, A. M., Batzinger, R. P., Ou, S. Y., Bueding, E., Cha, Y. N., and Talalay, P., Elevation of hepatic glutathione Stransferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res., 38, 4486-4495 (1978)
  3. Bloom, D. A. and Jaiswal, A. K., Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD (P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem., 278, 44675-44682 (2003) https://doi.org/10.1074/jbc.M307633200
  4. Brekke, O. L., Shalaby, M. R., Sundan, A., Espevik, T., and Bjerve, K. S., Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement. Cytokine, 4, 269-280 (1992) https://doi.org/10.1016/1043-4666(92)90067-2
  5. Cano, E., Hazzalin, C. A., and Mahadevan, L. C., Anisomycinactivated protein kinases p45 and p55 but not mitogenactivated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell. Biol., 14, 7352-7362 (1994) https://doi.org/10.1128/MCB.14.11.7352
  6. Cha, Y. N., Martz, F., and Bueding, E., Enhancement of liver microsome epoxide hydratase activity in rodents by treatment with 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res., 38, 4496-4498 (1978)
  7. Chen, C., Pung, D., Leong, V., Hebbar, V., Shen, G., Nair, S., Li, W., and Kong, A. N., Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radic. Biol. Med., 37, 1578-1590 (2004) https://doi.org/10.1016/j.freeradbiomed.2004.07.021
  8. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J., and Tan, T. H., The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem., 271, 31929-31936 (1996) https://doi.org/10.1074/jbc.271.50.31929
  9. Clayson, D. B., Iverson, F., Nera, E. A., and Lok, E., The significance of induced forestomach tumors. Annu. Rev. Pharmacol. Toxicol., 30, 441-463 (1990) https://doi.org/10.1146/annurev.pa.30.040190.002301
  10. Cobb, M. H. and Goldsmith, E. J., How MAP kinases are regulated. J. Biol. Chem., 270, 14843-14846 (1995) https://doi.org/10.1074/jbc.270.25.14843
  11. Cripe, L. D., Gelfanov, V. M., Smith, E. A., Spigel, D. R., Phillips, C. A., Gabig, T. G., Jung, S. H., Fyffe, J., Hartman, A. D., Kneebone, P., Mercola, D., Burgess, G. S., and Boswell, H. S., Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. Leukemia, 16, 799-812 (2002) https://doi.org/10.1038/sj.leu.2402457
  12. Cullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W., and Diehl, J. A., The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3- Keap1 ligase. Mol. Cell Biol., 24, 8477-8486 (2004) https://doi.org/10.1128/MCB.24.19.8477-8486.2004
  13. Cummings, S. W. and Prough, R. A., Butylated hydroxyanisolestimulated NADPH oxidase activity in rat liver microsomal fractions. J. Biol. Chem., 258, 12315-12319 (1983)
  14. Della Corte, L., Bianchi, L., Valoti, M., and Sgaragli, G., Distribution and peroxidative oxidation of 2-t-butyl-4-methoxyphenol in rat tissues after a single intraperitoneal dose. J. Biochem. Toxicol., 4, 147-150 (1989) https://doi.org/10.1002/jbt.2570040302
  15. Favreau, L. V. and Pickett, C. B., Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem., 266, 4556-4561 (1991)
  16. Friling, R. S., Bensimon, A., Tichauer, Y., and Daniel, V., Xenobiotic-inducible expression of murine glutathione Stransferase Ya subunit gene is controlled by an electrophileresponsive element. Proc. Natl. Acad. Sci. U.S.A., 87, 6258- 6262 (1990)
  17. Guan, J., Chen, X. P., Zhu, H., Luo, S. F., Cao, B., and Ding, L., Involvement of extracellular signal-regulated kinase/mitogenactivated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line. World J. Gastroenterol., 10, 3522-3527 (2004) https://doi.org/10.3748/wjg.v10.i23.3522
  18. Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., and Holbrook, N. J., Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem., 271, 4138-4142 (1996) https://doi.org/10.1074/jbc.271.8.4138
  19. Hayashi, T., Catanzaro, A., and Rao, S. P., Apoptosis of human monocytes and macrophages by Mycobacterium avium sonicate. Infect. Immun., 65, 5262-5271 (1997)
  20. Horvathova, E., Slamenova, D., Bonatti, S., and Abbondandolo, A., Reduction of genotoxic effects of MNNG by butylated hydroxyanisole. Neoplasma, 46, 356-362 (1999)
  21. Ichijo, H., From receptors to stress-activated MAP kinases. Oncogene, 18, 6087-6093 (1999) https://doi.org/10.1038/sj.onc.1203129
  22. Ito, N., Fukushima, S., Hagiwara, A., Shibata, M., and Ogiso, T., Carcinogenicity of butylated hydroxyanisole in F344 rats. J. Natl. Cancer. Inst., 70, 343-352 (1983a)
  23. Ito, N., Fukushima, S., Imaida, K., Sakata, T., and Masui, T., Induction of papilloma in the forestomach of hamsters by butylated hydroxyanisole. Gann., 74, 459-461 (1983b)
  24. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., and Nabeshima, Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun., 236, 313-322 (1997) https://doi.org/10.1006/bbrc.1997.6943
  25. Iverson, F., Truelove, J., Nera, E., Wong, J., Lok, E., and Clayson, D. B., An 85-day study of butylated hydroxyanisole in the cynomolgus monkey. Cancer. Lett., 26, 43-50 (1985) https://doi.org/10.1016/0304-3835(85)90171-5
  26. Kahl, R., Synthetic antioxidants: biochemical actions and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens. Toxicology, 33, 185- 228 (1984) https://doi.org/10.1016/0300-483X(84)90038-6
  27. King, M. M. and McCay, P. B., Modulation of tumor incidence and possible mechanisms of inhibition of mammary carcinogenesis by dietary antioxidants. Cancer. Res., 43, 2485s-2490s (1983)
  28. Kirlin, W. G., Cai, J., DeLong, M. J., Patten, E. J., and Jones, D. P., Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J. Nutr., 129, 1827-1835 (1999) https://doi.org/10.1093/jn/129.10.1827
  29. Kong, A. N., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., and Mandlekar, S., Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug. Metab. Rev., 33, 255- 271 (2001) https://doi.org/10.1081/DMR-120000652
  30. Kraft, A. D., Johnson, D. A., and Johnson, J. A., Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci., 24, 1101-1112 (2004) https://doi.org/10.1523/JNEUROSCI.3817-03.2004
  31. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R., The stressactivated protein kinase subfamily of c-Jun kinases. Nature, 369, 156-160 (1994) https://doi.org/10.1038/369156a0
  32. Lam, L. K., Fladmoe, A. V., Hochalter, J. B., and Wattenberg, L. W., Short time interval effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene. Cancer. Res., 40, 2824- 2828 (1980)
  33. Li, Y. and Jaiswal, A. K., Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J. Biol. Chem., 267, 15097-15104 (1992)
  34. Liu, Y., Guyton, K. Z., Gorospe, M., Xu, Q., Lee, J. C., and Holbrook, N. J., Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic. Biol. Med., 21, 771- 781 (1996) https://doi.org/10.1016/0891-5849(96)00176-1
  35. Logan, S. K., Falasca, M., Hu, P., and Schlessinger, J., Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway. Mol. Cell Biol., 17, 5784-5790 (1997) https://doi.org/10.1128/MCB.17.10.5784
  36. Marshall, C. J., MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet Dev., 4, 82-89 (1994) https://doi.org/10.1016/0959-437X(94)90095-7
  37. Moldeus, P., Dock, L., Cha, Y. N., Berggren, M., and Jernstrom, B., Elevation of conjugation capacity in isolated hepatocytes from BHA-treated mice. Biochem. Pharmacol., 31, 1907-1910 (1982) https://doi.org/10.1016/0006-2952(82)90496-8
  38. Monroe, D. H. and Eaton, D. L., Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse. Toxicol Appl Pharmacol, 90, 401-409 (1987) https://doi.org/10.1016/0041-008X(87)90132-3
  39. Nera, E. A., Iverson, F., Lok, E., Armstrong, C. L., Karpinski, K., and Clayson, D. B., A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male Fischer 344 rats. Toxicology, 53, 251-268 (1988) https://doi.org/10.1016/0300-483X(88)90218-1
  40. Ohmichi, M., Sawada, T., Kanda, Y., Koike, K., Hirota, K., Miyake, A., and Saltiel, A. R., Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. J. Biol. Chem., 269, 3783-3788 (1994)
  41. Peters, M. M., Rivera, M. I., Jones, T. W., Monks, T. J., and Lau, S. S., Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butylhydroxyanisole, are toxic to kidney and bladder. Cancer. Res., 56, 1006-1011 (1996)
  42. Prochaska, H. J., De Long, M. J., and Talalay, P., On the mechanisms of induction of cancer-protective enzymes: a unifying proposal. Proc. Natl. Acad. Sci U.S.A., 82, 8232- 8236 (1985)
  43. Ratan, R. R., Murphy, T. H., and Baraban, J. M., Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem., 62, 376-379 (1994) https://doi.org/10.1046/j.1471-4159.1994.62010376.x
  44. Reddy, B. S. and Maeura, Y., Dose-response studies of the effect of dietary butylated hydroxyanisole on colon carcinogenesis induced by methylazoxymethanol acetate in female CF1 mice. J. Natl. Cancer. Inst., 72, 1181-1187 (1984)
  45. Rehwoldt, R., Tracking the use of antioxidants through industry surveys. Food Chem. Toxicol., 24, 1039-1041 (1986) https://doi.org/10.1016/0278-6915(86)90286-3
  46. Rushmore, T. H. and Pickett, C. B., Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem., 265, 14648-14653 (1990)
  47. Rushmore, T. H., Morton, M. R., and Pickett, C. B., The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem., 266, 11632- 11639 (1991)
  48. Sakai, A., Miyata, N., and Takahashi, A., Initiating activity of 3- tert-butyl-4-hydroxyanisole (3-BHA) and its metabolites in two-stage transformation of BALB/3T3 cells. Carcinogenesis, 11, 1985-1988 (1990) https://doi.org/10.1093/carcin/11.11.1985
  49. Shen, G., Hebbar, V., Nair, S., Xu, C., Li, W., Lin, W., Keum, Y. S., Han, J., Gallo, M. A., and Kong, A. N., Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. J. Biol. Chem., 279, 23052-23060 (2004) https://doi.org/10.1074/jbc.M401368200
  50. Sparnins, V. L., Chuan, J., and Wattenberg, L. W., Enhancement of glutathione S-transferase activity of the esophagus by phenols, lactones, and benzyl isothiocyanate. Cancer. Res., 42, 1205-1207 (1982a)
  51. Sparnins, V. L., Venegas, P. L., and Wattenberg, L. W., Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. J. Natl. Cancer. Inst., 68, 493-496 (1982b)
  52. Talalay, P., Batzinger, R. P., Benson, A. M., Bueding, E., and Cha, Y. N., Biochemical studies on the mechanisms by which dietary antioxidants suppress mutagenic activity. Adv. Enzyme. Regul., 17, 23-36 (1978) https://doi.org/10.1016/0065-2571(79)90006-2
  53. Taylor, M. J., Sharma, R. P., and Bourcier, D. R., Tissue distribution and pharmacokinetics of 3H-butylated hydroxyanisole in female mice. Agents Actions, 15, 454-458 (1984) https://doi.org/10.1007/BF01972387
  54. Venugopal, R. and Jaiswal, A. K., Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. U.S.A., 93, 14960-14965 (1996)
  55. Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., and Vandenabeele, P., Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med., 187, 1477-1485 (1998) https://doi.org/10.1084/jem.187.9.1477
  56. Verhagen, H., Beckers, H. H., Comuth, P. A., Maas, L. M., ten Hoor, F., Henderson, P. T., and Kleinjans, J. C., Disposition of single oral doses of butylated hydroxytoluene in man and rat. Food Chem. Toxicol., 27, 765-772 (1989) https://doi.org/10.1016/0278-6915(89)90105-1
  57. Vojtek, A. B. and Der, C. J., Increasing complexity of the Ras signaling pathway. J. Biol. Chem., 273, 19925-19928 (1998) https://doi.org/10.1074/jbc.273.32.19925
  58. Vora, J., Wu, Z., Montague, M., Penn, M., and Erow, K., Influence of dosing vehicles on the preclinical pharmacokinetics of phenolic antioxidants. Res. Commun. Mol. Pathol. Pharmacol., 104, 93-106 (1999)
  59. Wattenberg, L. W., Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole. J. Natl. Cancer. Inst., 50, 1541-1544 (1973) https://doi.org/10.1093/jnci/50.6.1541
  60. Wattenberg, L. W., Inhibition of neoplasia by minor dietary constituents. Cancer. Res., 43, 2448s-2453s (1983)
  61. Wattenberg, L. W., Chemoprevention of cancer. Cancer. Res., 45, 1-8 (1985) https://doi.org/10.1016/S0065-230X(08)60265-1
  62. Wood, K. W., Sarnecki, C., Roberts, T. M., and Blenis, J., ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell, 68, 1041-1050 (1992) https://doi.org/10.1016/0092-8674(92)90076-O
  63. Wu, J., Rossomando, A. J., Her, J. H., Del Vecchio, R., Weber, M. J., and Sturgill, T. W., Autophosphorylation in vitro of recombinant 42-kilodalton mitogen-activated protein kinase on tyrosine. Proc. Natl. Acad. Sci. U.S.A., 88, 9508-9512 (1991)
  64. Wurtzen, G. and Olsen, P., BHA study in pigs. Food Chem. Toxicol., 24, 1229-1233 (1986) https://doi.org/10.1016/0278-6915(86)90311-X
  65. Yu, R., Tan, T. H., and Kong, A. T., Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J. Biol. Chem., 272, 28962- 28970 (1997) https://doi.org/10.1074/jbc.272.46.28962
  66. Yu, R., Mandlekar, S., and Kong, A. T., Molecular mechanisms of butylated hydroxylanisole-induced toxicity: induction of apoptosis through direct release of cytochrome c. Mol. Pharmacol., 58, 431-437 (2000) https://doi.org/10.1124/mol.58.2.431
  67. Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., and Kong, A. T., Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem., 274, 27545-27552 (1999) https://doi.org/10.1074/jbc.274.39.27545